Terms of Use
These Terms of Use ("Terms") govern your access to and use of thecompoundbrief.com and any newsletter, lead magnet, or other content published under The Compound brand (collectively, the "Service"). By using the Service, you agree to these Terms.
Research-use-only and no-medical-advice notice
The Compound is a research-focused editorial publication. Compounds discussed in any issue, lead magnet, or page on this site are referenced for research and educational purposes only. The Compound does not sell compounds. Any compounds purchased through a related vendor are sold by that vendor for laboratory research purposes only and are not for human or animal consumption. Nothing on this Service is medical advice. Nothing is a recommendation to administer, prescribe, or self-administer any compound. Several of the compounds discussed are not approved for human use in the United States, or are approved only for specific indications under prescription. No statement here has been evaluated by the U.S. Food and Drug Administration. If you are managing a clinical condition, consult a qualified medical professional. Use of this Service does not create a doctor-patient relationship.
1. Eligibility
The Service is intended for use by adults 18 years of age or older. By using the Service you represent that you are at least 18 years old.
2. License to use
We grant you a limited, non-exclusive, non-transferable, revocable license to access the Service and read its content for your own personal, non-commercial research and educational purposes. You may forward individual issues to colleagues and peers; you may not republish, sell, or systematically scrape the content without prior written permission.
3. User conduct
You agree not to:
- Use the Service in any way that violates applicable law.
- Attempt to gain unauthorized access to any portion of the Service.
- Use any automated means (bots, scrapers, harvesters) to collect data from the Service without our written consent.
- Reproduce, distribute, or commercially exploit the Service's content beyond personal forwarding.
4. Affiliate / commercial relationships
The Compound is an editorial brand that is operationally and financially related to Heroxbio.com, an RUO peptide vendor owned by the same operator. That relationship is disclosed on the About page and in the standing footer of every issue, in compliance with FTC guidance on material connections in endorsements (16 CFR Part 255). Editorial decisions are independent of vendor relationships, and customer testimonials with health claims are not published anywhere on this Service.
5. Disclaimers and limitation of liability
The Service is provided on an "as is" and "as available" basis. To the fullest extent permitted by law, we disclaim all warranties, whether express or implied, including without limitation warranties of merchantability, fitness for a particular purpose, and non-infringement.
To the fullest extent permitted by law, in no event shall The Compound, its operator(s), or their affiliates be liable for any indirect, incidental, special, consequential, or punitive damages arising out of or in connection with your use of the Service, even if advised of the possibility of such damages. Total cumulative liability shall not exceed one hundred US dollars ($100).
6. Indemnification
You agree to indemnify, defend, and hold harmless The Compound and its operator(s) from any claims, losses, or expenses (including reasonable attorneys' fees) arising out of your breach of these Terms or your misuse of the Service, including but not limited to any decision you make based on content read here.
7. Termination
We may suspend or terminate your access to the Service at any time, with or without cause, including but not limited to breaches of these Terms. You may unsubscribe from the newsletter at any time using the unsubscribe link in any issue.
8. Governing law and dispute resolution
These Terms are governed by the laws of the State of Delaware (or the LLC's state of formation) without regard to its conflict-of-laws principles. Any dispute arising from these Terms or your use of the Service shall be resolved by binding arbitration administered by the American Arbitration Association under its Commercial Arbitration Rules, with the seat of arbitration in Fort Lauderdale.
9. Changes
We may update these Terms from time to time. Material changes will be communicated to current subscribers via email and dated on this page. Continued use of the Service after the effective date of an update constitutes acceptance of the updated Terms.
10. Contact
Questions about these Terms: hello@thecompoundbrief.com.
Mailing address: Vault IQ LLC, 1126 S Federal Hwy Suite 704, Fort Lauderdale, FL 33316.